Mortezavi, Ashkan

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 5.

Journal Article

Scherer, Thomas P; Saba, Karim; Wettstein, Marian S; Lucca, Ilaria; Mortezavi, Ashkan; Waisbrod, Sharon; Aujesky, Drahomir; Capaul, Regula; Strebel, Raeto T (2023). Do Swiss urologists and Swiss internists screen themselves and their relatives for prostate cancer? A questionnaire study. Swiss medical weekly, 153(40115), p. 40115. EMH Schweizerischer Ärzteverlag 10.57187/smw.2023.40115

Mortezavi, Ashkan; Salemi, Souzan; Kranzbühler, Benedikt; Gross, Oliver; Sulser, Tullio; Simon, Hans-Uwe; Eberli, Daniel (2019). Inhibition of autophagy significantly increases the antitumor effect of Abiraterone in prostate cancer. World journal of urology, 37(2), pp. 351-358. Springer-Verlag 10.1007/s00345-018-2385-5

Eberli, Daniel; Horst, Maya; Mortezavi, Ashkan; Andersson, Karl-Erik; Gobet, Rita; Sulser, Tullio; Simon, Hans-Uwe; Salemi, Souzan (2018). Increased autophagy contributes to impaired smooth muscle function in neurogenic lower urinary tract dysfunction. Neurourology and urodynamics, 37(8), pp. 2414-2424. Wiley-Liss 10.1002/nau.23705

Mortezavi, Ashkan; Salemi, Souzan; Rupp, Niels J; Rüschoff, Jan Hendrik; Hermanns, Thomas; Poyet, Cedric; Randazzo, Marco; Simon, Hans-Uwe; Moch, Holger; Sulser, Tullio; Wild, Peter; Eberli, Daniel (2017). Negative LC3b immunoreactivity in cancer cells is an independent prognostic predictor of prostate cancer specific death. OncoTarget, 8(19), pp. 31765-31774. Impact Journals LLC 10.18632/oncotarget.15986

Mortezavi, Ashkan; Hermanns, Thomas; Seifert, Hans-Helge; Baumgartner, Martin K; Provenzano, Maurizio; Sulser, Tullio; Burger, Maximilian; Montani, Matteo; Ikenberg, Kristian; Hofstädter, Ferdinand; Hartmann, Arndt; Jaggi, Rolf; Moch, Holger; Kristiansen, Glen; Wild, Peter J (2011). KPNA2 expression is an independent adverse predictor of biochemical recurrence after radical prostatectomy. Clinical cancer research, 17(5), pp. 1111-21. Philadelphia, Pa.: American Association for Cancer Research 10.1158/1078-0432.CCR-10-0081

This list was generated on Fri Apr 19 12:33:01 2024 CEST.
Provide Feedback